vs
和黄医药（HCM）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是和黄医药的1.3倍（$362.7M vs $270.8M），和黄医药净利率更高（0.7% vs -10.7%，领先11.4%），和黄医药自由现金流更多（$3.4M vs $-193.1M）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
HCM vs VNET — 直观对比
营收规模更大
VNET
是对方的1.3倍
$270.8M
净利率更高
HCM
高出11.4%
-10.7%
自由现金流更多
HCM
多$196.4M
$-193.1M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $362.7M |
| 净利润 | $2.0M | $-38.7M |
| 毛利率 | 37.7% | 20.9% |
| 营业利润率 | -13.2% | 0.5% |
| 净利率 | 0.7% | -10.7% |
| 营收同比 | -16.5% | — |
| 净利润同比 | -83.6% | — |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMVNET
| Q4 25 | $270.8M | — | ||
| Q3 25 | — | $362.7M | ||
| Q2 25 | $277.7M | — | ||
| Q1 25 | $324.5M | $309.5M | ||
| Q3 24 | — | $302.2M | ||
| Q2 24 | $305.7M | $274.4M | ||
| Q1 24 | — | $262.9M | ||
| Q3 23 | — | $258.6M |
净利润HCMVNET
| Q4 25 | $2.0M | — | ||
| Q3 25 | — | $-38.7M | ||
| Q2 25 | $455.0M | — | ||
| Q1 25 | $11.9M | $-2.4M | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | $25.8M | $-1.1M | ||
| Q1 24 | — | $-22.0M | ||
| Q3 23 | — | $-5.5M |
毛利率HCMVNET
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | 25.2% | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | 41.1% | 21.3% | ||
| Q1 24 | — | 21.6% | ||
| Q3 23 | — | 16.2% |
营业利润率HCMVNET
| Q4 25 | -13.2% | — | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -5.0% | 0.1% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | -9.0% | 0.2% | ||
| Q1 24 | — | 0.2% | ||
| Q3 23 | — | 1.7% |
净利率HCMVNET
| Q4 25 | 0.7% | — | ||
| Q3 25 | — | -10.7% | ||
| Q2 25 | 163.8% | — | ||
| Q1 25 | 3.7% | -0.8% | ||
| Q3 24 | — | -0.7% | ||
| Q2 24 | 8.4% | -0.4% | ||
| Q1 24 | — | -8.4% | ||
| Q3 23 | — | -2.1% |
每股收益（稀释后）HCMVNET
| Q4 25 | $0.00 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $492.1M |
| 总债务越低越好 | $93.2M | — |
| 股东权益账面价值 | $1.2B | $890.8M |
| 总资产 | $1.8B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMVNET
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | $492.1M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | $544.3M | ||
| Q3 24 | — | $219.5M | ||
| Q2 24 | $802.5M | $247.2M | ||
| Q1 24 | — | $246.9M | ||
| Q3 23 | — | $370.4M |
总债务HCMVNET
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
股东权益HCMVNET
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | $890.8M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $759.9M | $927.8M | ||
| Q3 24 | — | $902.9M | ||
| Q2 24 | $740.1M | $900.6M | ||
| Q1 24 | — | $895.1M | ||
| Q3 23 | — | $942.7M |
总资产HCMVNET
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.3B | $5.4B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | $1.3B | $4.0B | ||
| Q1 24 | — | $3.9B | ||
| Q3 23 | — | $4.1B |
负债/权益比HCMVNET
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $-193.1M |
| 自由现金流率自由现金流/营收 | 1.2% | -53.2% |
| 资本支出强度资本支出/营收 | 1.8% | 84.6% |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流HCMVNET
| Q4 25 | $8.2M | — | ||
| Q3 25 | — | $113.8M | ||
| Q2 25 | $-72.9M | — | ||
| Q1 25 | $40.3M | $27.0M | ||
| Q3 24 | — | $108.3M | ||
| Q2 24 | $-39.8M | $55.8M | ||
| Q1 24 | — | $37.1M | ||
| Q3 23 | — | $62.3M |
自由现金流HCMVNET
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | $-193.1M | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | $-220.0M | ||
| Q3 24 | — | $-95.0M | ||
| Q2 24 | $-49.9M | $-81.6M | ||
| Q1 24 | — | $-102.2M | ||
| Q3 23 | — | $-67.5M |
自由现金流率HCMVNET
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | -53.2% | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | -71.1% | ||
| Q3 24 | — | -31.4% | ||
| Q2 24 | -16.3% | -29.8% | ||
| Q1 24 | — | -38.9% | ||
| Q3 23 | — | -26.1% |
资本支出强度HCMVNET
| Q4 25 | 1.8% | — | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | 79.8% | ||
| Q3 24 | — | 67.3% | ||
| Q2 24 | 3.3% | 50.1% | ||
| Q1 24 | — | 53.0% | ||
| Q3 23 | — | 50.2% |
现金转化率HCMVNET
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
